tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

JNJJohnson & Johnson

Health care · Pharmaceuticals · NYSE
Compare with peers → Embed
Revised numbers, fiscal years since 2021

4 numbers reported differently in a later 10-K

XBRL, 6 10-Ks
Numbers revised
4
changes of 0.5% or more
Restatements
0
the company said the earlier number was wrong (8-K item 4.02)
Largest change
-17.7%
Inventory, At 2023-01-01

A change is a restatement (the company says the earlier number was wrong) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.

Number by number

First reported, then reported again

Each number links to its 10-K
NumberPeriodFirst reportedLater reportedChangeWhy
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax · link
Fiscal year ending 2023-01-01 $94.94B
10-K filed 2023-02-16
$79.99B
10-K filed 2024-02-16
-15.8% Recast or revision
Receivables
AccountsReceivableNetCurrent · link
At 2023-01-01 $16.16B
10-K filed 2023-02-16
$14.04B
10-K filed 2024-02-16
-13.1% Recast or revision
Inventory
InventoryNet · link
At 2023-01-01 $12.48B
10-K filed 2023-02-16
$10.27B
10-K filed 2024-02-16
-17.7% Recast or revision
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax · link
Fiscal year ending 2022-01-02 $93.78B
10-K filed 2022-02-17
$78.74B
10-K filed 2024-02-16
-16.0% Recast or revision

From SEC's XBRL company facts (6 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.

Next Footnotes →